ZLB Technology definition

ZLB Technology means all of ZLB Bioplasma's rights and other assets used, owned or controlled by ZLB Bioplasma relating directly to the research, development, manufacture, use, registration, and/or sale of the Products or Devices as of the Effective Date of this Agreement including, without limitation, all conceptions, innovations, inventions, formulations, trade secrets, know-how, specifications (chromatography parameters and the like), designs, drawings, processes, pre-clinical and clinical data, dossiers, SOP manuals, pharmacological, clinical, and medical data, health registration data, production information, manufacturing information, testing and quality control data, research materials, software, code, copyrights, information stored in management information systems (and specifications sufficient for HAE to use such information), all information in the possession of ZLB Bioplasma pursuant to the obligations of the 1999 Agreements and related to the HMN Project, and all data, contractual rights, materials and information relating to FDA and other governmental or regulatory approvals.
View Source
ZLB Technology means all patents, patent applications, technical information, know-how, experience, trade secrets, clinical data and information, including but not limited to product specifications, formulations, designs, dossiers, uses, processes and toxicological, pharmacological, clinical and medical data, health registration data, related to the manufacture, use registration and sale developed, owned or controlled by ZLB relating to the Products.
View Source

Examples of ZLB Technology in a sentence

  • The parties shall mutually agree in writing on procedures for the memorialization of each ZLB Technology transfer, including keeping a transfer log of all documents provided to HAE.

  • ZLB Bioplasma hereby assigns and agrees to assign to HAE the entire right, title and interest in all patents or patent applications for ZLB Technology.

  • ZLB Bioplasma agrees that, for a period of five (5) years from the Effective Date, it shall not use or utilize any ZLB Technology for any project to develop, manufacture or sell fibrinogen and thrombin combined.

  • Notwithstanding Section 3.1, HAE shall have the right, in its sole discretion, and at its own cost, to pursue patent protection for ZLB Technology inventions, wherein ZLB agrees to provide all reasonable assistance to HAE in obtaining and enforcing proper title in and protection for ZLB Technology inventions under the intellectual property laws of the United States and countries foreign thereto.

  • ZLB hereby grants HAE a non-exclusive world-wide license to use, sell, offer for sale and import any and all Products, including any and all rights in ZLB Technology necessary to use, sell, offer for sale and import the Products.